195 related articles for article (PubMed ID: 19303072)
1. The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study.
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Ruotolo G; Stehouwer CD; Heine RJ; Eliasson M; Zethelius B;
Atherosclerosis; 2009 Sep; 206(1):298-302. PubMed ID: 19303072
[TBL] [Abstract][Full Text] [Related]
2. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
DECODE Study Group, European Diabetes Epidemiology Group
Diabetes Care; 2003 Mar; 26(3):688-96. PubMed ID: 12610023
[TBL] [Abstract][Full Text] [Related]
3. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.
Hanefeld M; Koehler C; Henkel E; Fuecker K; Schaper F; Temelkova-Kurktschiev T
Diabet Med; 2000 Dec; 17(12):835-40. PubMed ID: 11168325
[TBL] [Abstract][Full Text] [Related]
4. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.
Barr EL; Boyko EJ; Zimmet PZ; Wolfe R; Tonkin AM; Shaw JE
Diabetologia; 2009 Mar; 52(3):415-24. PubMed ID: 19130039
[TBL] [Abstract][Full Text] [Related]
5. Different glucose tolerance status and incident cardiovascular disease and all-cause mortality among elderly Iranians.
Mirbolouk M; Hajebrahimi MA; Akbarpour S; Tohidi M; Azizi F; Hadaegh F
Geriatr Gerontol Int; 2016 Dec; 16(12):1263-1271. PubMed ID: 26463623
[TBL] [Abstract][Full Text] [Related]
6. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
[TBL] [Abstract][Full Text] [Related]
7. Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study.
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Janus ED; Söderberg S; Mohan V; Ramachandran A; Dong YH; Lam TH; Pang ZC
Diabetes Metab Res Rev; 2009 Sep; 25(6):549-57. PubMed ID: 19585489
[TBL] [Abstract][Full Text] [Related]
8. Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study.
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Alberti KG; Eliasson M; Heine RJ; Stehouwer CD; Ruotolo G;
Diabetes Res Clin Pract; 2008 Dec; 82(3):364-77. PubMed ID: 18922596
[TBL] [Abstract][Full Text] [Related]
9. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study.
Barrett-Connor E; Ferrara A
Diabetes Care; 1998 Aug; 21(8):1236-9. PubMed ID: 9702426
[TBL] [Abstract][Full Text] [Related]
10. Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study.
Chen Z; Hu H; Chen M; Luo X; Yao W; Liang Q; Yang F; Wang X
Lipids Health Dis; 2020 Mar; 19(1):33. PubMed ID: 32131838
[TBL] [Abstract][Full Text] [Related]
11. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
[TBL] [Abstract][Full Text] [Related]
12. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status.
Liu X; Yang Y; Kang F; Li J; Zhou M; Ma X; Yu T; Zhang T; Xue F
Am J Cardiol; 2019 Sep; 124(5):702-708. PubMed ID: 31311663
[TBL] [Abstract][Full Text] [Related]
15. Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
Luksiene D; Tamosiunas A; Baceviciene M; Radisauskas R; Malinauskiene V; Peasey A; Bobak M
PLoS One; 2014; 9(6):e100158. PubMed ID: 24955583
[TBL] [Abstract][Full Text] [Related]
16. The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study.
Abdi A; Kohansal K; Khalili D; Azizi F; Hadaegh F
Nutr Metab (Lond); 2024 Feb; 21(1):10. PubMed ID: 38389086
[TBL] [Abstract][Full Text] [Related]
17. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register.
Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Zethelius B; Cederholm J;
Diabetologia; 2011 Oct; 54(10):2544-51. PubMed ID: 21674176
[TBL] [Abstract][Full Text] [Related]
19. Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study.
Barzin M; Hosseinpanah F; Malboosbaf R; Hajsheikholeslami F; Azizi F
Diab Vasc Dis Res; 2013 Jul; 10(4):324-9. PubMed ID: 23291339
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.
Ning F; Tuomilehto J; Pyörälä K; Onat A; Söderberg S; Qiao Q;
Diabetes Care; 2010 Oct; 33(10):2211-6. PubMed ID: 20424221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
